Ibrutinib Plus Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Results from a Multicenter, Phase 2 StudyNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|Blood|2015Cited by 35
The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphomaNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|British Journal of Haematology|2020Cited by 28
Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1 + Arm 2 Results from a Multicenter, Open-Label Phase 2 StudyNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|Blood|2016Cited by 9
0132 The effect of zoledronic acid in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant letrozole: 24 months integrated follow-up of the Z-FAST/ZO-FAST trialsAntonio Frassoldati, RE Coleman, Adam Brufsky et al.|The Breast|2009Cited by 5